2025 Annual Report

"Hikma celebrated the twentieth anniversary of our listing on the London Stock Exchange during 2025 – a milestone I’m hugely proud of. When we first listed we had six manufacturing plants, employed fewer than 2,000 people and generated $262 million in revenue. We now have 29 manufacturing plants, employ over 9,400 people and generate over $3.3 billion in revenue with enviable margins and cash generation. But more important than the growth we have delivered is the impact we have had on patients, providing vital, more affordable medicines to those who need them."

Said Darwazah Chief Executive Officer